Breast Cancer Patient

Breast Cancer Patient - most related articles:

- 7% breast cancer patients have breast reconstruction surgery - 6
- Breast cancer drug Tykerb to be subsidised - 5.3
- Breast cancer screening should begin at age 40 - 5.1
- Breastfeeding mothers reduce breast cancer risk - 5
- Breast cancer recurrence high in women with dense breasts - 4.9
- Preventive mastectomy decision for breast cancer patient - 4.9
- Exercise reduces breast cancer risk - 4.8
- Breast stem cell fate is regulated by notch - 4.8
- New consensus on using APBI to treat breast cancer - 4.7
- Aggressive breast cancer risk higher for black women - 4.7

Breast Cancer Patient articles

Whole genome breast cancer study launched by Mayo Clinic USA
The Breast Cancer Genome Guided Therapy Study (BEAUTY Project) will help physicians tailor chemotherapy to breast cancer patients based on their individual genomes and the genomes of their tumors.

Additional breast surgery common after partial mastectomy
Nearly one in four women who undergo a partial mastectomy for treatment of breast cancer have another surgery to remove additional tissue (reexcision), and there is substantial surgeon and institutional variation in the rate of reexcisions that cannot be explained by patients' clinical characteristics.

Cancer screening in older adults appears common, US
A high percentage of adults age 75 years and older continue to report receiving cancer screenings, despite U.S. Preventive Services Task Force guidelines recommending against routine screening for breast, cervical, colorectal and prostate cancer for patients age 75 years and older.

HER growth proteins do not predict outcome of herceptin treatment breast cancer patients
Precisely quantifying the amount of three different HER growth proteins, along with several other proteins believed linked to breast cancer, did not predict a patient's outcome after treatment for HER2 Positive Breast Cancer with Herceptin, say Mayo Clinic researchers.

7% breast cancer patients have breast reconstruction surgery
Breast reconstruction surgery has a very positive effort on women with breast cancer as they go through their breast cancer journey. Only 7% of female breast cancer patients opt for breast reconstruction surgery.

$3.5 million Komen award to study rare and aggressive type of breast cancer
The Translational Genomics Research Institute (TGen) is part of a team of medical investigators receiving a $3.5 million grant from Susan G. Komen for the Cure to study triple-negative breast cancer, a highly aggressive form of this cancer that disproportionately affects African-Americans.

FDA panel votes to revoke approval for Avastin for advanced breast cancer
The Oncologic Drugs Advisory Committee, FDA, USA disapproved the Avastin which cited a lack of survival benefit. Now as two more trials have been analyzed -- neither showing a survival benefit -- the FDA stated that in the balance, the benefit did not outweigh the harm.

Many advanced breast cancer patients do not receive recommended treatment
Forty-five percent of women with advanced breast cancer in the U.S. did not receive postmastectomy radiation therapy (PMRT) despite the publication of evidence-based guidelines outlining PMRT as a potentially lifesaving treatment, according to new research from The University of Texas MD Anderson Cancer Center. The study, published in the July issue of Cancer, found that PMRT use rates for women with advanced breast cancer have remained static since 1999.

Inform Dual ISH to determine HER2 gene in breast cancer patients
Breast cancer is the second leading cause of cancer-related death among women. About 20 percent of women diagnosed with breast cancer are HER2-positive. The Inform Dual ISH test allows lab personnel to count the number of copies of HER2 genes on chromosome 17 in a small sample of the breast tumor. Copies of the HER2 gene appear black and copies of chromosome 17 appear red. Patients with more than the normal number of copies of the HER2 gene are considered candidates for Herceptin therapy.

Radiation improves survival in breast cancer surgery patients
Additional radiation treatment improves disease free survival lessening the chance of cancer recurring in women with early breast cancer who have had breast conserving surgery (lumpectomy), interim results of a new study found. The results will be presented Monday, June_6 at the annual meeting of the American Society of Clinical Oncology.

New class of cancer drugs could work in colon cancers with genetic mutation
A class of drugs that shows promise in breast and ovarian cancers with BRCA gene mutations could potentially benefit colorectal cancer patients with a different genetic mutation, a new study from the University of Michigan Comprehensive Cancer Center finds.

Preventive surgeries better in breast or ovarian cancer patients
A long-term study of women with a genetic predisposition for breast or ovarian cancer showed that those who elected major preventive surgeries had a significantly reduced risk of those cancers.

49% breast cancer patients adhere to hormonal therapy regimen
A new study of nearly 8,800 women with early-stage breast cancer found that fewer than half – approximately 49 percent – completed their full regimen of hormone therapy according to the prescribed schedule.

Exercise may keep cancer patients healthier
Breast and prostate cancer patients who regularly exercise during and after cancer treatment report having a better quality of life and being less fatigued, according to researchers at Henry Ford Hospital in Detroit.

Estrogen lowering drugs minimize surgery in breast cancer patients
A US study has confirmed the benefit of giving estrogen-lowering drugs before surgery to breast cancer patients. The treatment increased the likelihood that women could undergo breast-conservation surgery, also called lumpectomy, instead of mastectomy.

BRCA mutation increases breast cancer risk in opposite breast
Women with breast cancer before age 55 who carry an inherited mutation in the breast cancer susceptibility genes BRCA1 or BRCA2 are four times more likely to develop cancer in the breast opposite, or contralateral, to their initial tumor as compared to breast cancer patients without these genetic defects.

Breast cancer screening should begin at age 40
Breast cancer screening should begin at age 40 and earlier in high-risk patients, suggested by the Society of Breast Imaging (SBI) and the American College of Radiology (ACR).

Newly diagnosed breast cancer patients and MRI
New research findings published in the August issue of the Journal of the American College of Surgeons challenge the routine use of magnetic resonance imaging (MRI) as a means to improve surgical outcomes in newly diagnosed breast cancer patients.

Math may predict Herceptin response in breast cancer patients
Cancer researchers are turning to mathematical models to help answer important clinical questions, and a new paper in Cancer Research, a journal of the American Association for Cancer Research, illustrates how the technique may answer questions about Herceptin resistance.

Antioxidant supplements may interfere breast cancer treatment
A new study finds that many women with breast cancer take antioxidant supplements while undergoing cancer treatment, even though the consequences of doing so are unknown.

Breast cancer markers discovered in breast cancer survivors
A study led by researchers at Fred Hutchinson Cancer Research Center has identified two proteins in the blood that could become important prognostic markers for long-term survival in breast cancer patients.

Low income breast cancer patients skipping hormonal therapy
Many low-income women are failing to take the hormonal therapy prescribed as part of their breast cancer treatment, possibly lowering their survival rates, according to a study led by a researcher in the Duke Comprehensive Cancer Center.

Chemotherapy improves survival among older breast cancer patients
The average age of a woman diagnosed with breast cancer is 63, so it is critical to have effective proven, therapies for an older patient population.

$5.9 million grant for breast cancer research
Richard Junghans, MD, associate professor of surgery at Boston University School of Medicine (BUSM) and Chief of Surgical Research was named principal investigator of a grant to research how breast cancer patients' own cells can be modified to fight their disease.

New genomic test to personalize breast cancer treatment
A set of 50 genes can be used to reliably identify the four known types of breast cancer, according to research conducted at Washington University School of Medicine in St. Louis and collaborating institutions.

New test to predict chemotherapy response in breast cancer patients
Researchers at the Swiss Institute of Bioinformatics and the Swiss National Center of Competence in Research in Molecular Oncology in Lausanne have developed a new test to predict how breast cancer patients respond to chemotherapy, which could help change how treatment is delivered in the future.

Preventive mastectomy decision for breast cancer patient
A preventive procedure to remove the unaffected breast in breast cancer patients with disease in one breast may only be necessary in patients who have high-risk features as assessed by examining the patient's medical history and pathology of the breast cancer, according to researchers at The University of Texas M. D. Anderson Cancer Center.

Psychotherapy improves survival for breast cancer patients
A new study finds that breast cancer patients who participate in intervention sessions focusing on improving mood, coping effectively, and altering health behaviors live longer than patients who do not receive such psychological support.

$19 Million to M. D. Anderson for breast cancer research
The University of Texas M. D. Anderson Cancer Center has received nearly $19 million in grants from Susan G. Komen for the Cure® as part of that organization's new initiative to fast-track promising research to benefit breast cancer patients.

1 week radiation effective breast cancer treatment
Accelerated partial breast irradiation (APBI) using a type of radiation seed implants called balloon brachytherapy is as effective in keeping breast cancer from coming back as the standard external beam radiation treatment.

Acupuncture reduces side effects of breast cancer treatment
Acupuncture is as effective and longer-lasting in managing the common debilitating side effects of hot flashes, night sweats, and excessive sweating (vasomotor symptoms) associated with breast cancer treatment and has no treatment side effects compared to conventional drug therapy, according to a first-of-its-kind study presented September 24, 2008, at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting in Boston.

Lumpectomy, radiation improve life in breast cancer patients
Women with breast cancer who are treated with lumpectomy and radiation report a high level of overall quality of life several years after treatment that is comparable to a general sampling of the adult women U.S. population according to a survey conducted by physicians at Fox Chase Cancer Center.

SPOT-Light HER2 CISH kit approved for breast cancer patients
SPOT-Light HER2 CISH kit - a novel genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin (trastuzumab) has been approved by the U.S. Food and Drug Administration.

Short radiotherapy benefits breast cancer patients
A lower total dose of radiotherapy, delivered in fewer, larger treatments has been shown to be as effective as the international standard of a higher total dose delivered over a longer time to treat women with early breast cancer – according to new research published in the Lancet and Lancet Oncology today.

Lower heart effects from Herceptin breast cancer treatment with chemotherapy
A new pilot study by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) found that breast cancer patients can be treated safely with a "dose-dense" regimen of standard chemotherapy agents and the antibody trastuzumab (Herceptin), a drug that has previously been shown to cause cardiac toxicity.

Avastin found effective in advanced breast cancer patients
Genentech, Inc. (NYSE: DNA) announced that AVADO, a Roche-sponsored Phase III, placebo-controlled study evaluating Avastin® (bevacizumab) in combination with docetaxel chemotherapy met its primary endpoint of prolonging progression-free survival (PFS) in patients who had not received prior chemotherapy for their locally recurrent or metastatic HER2-negative breast cancer.

21% errors in pathology reports in Miramichi Hospital, New Brunswick
An additional review of pathology reports in Miramichi Hospital, New Brunswick is completed by Dr. Rosemary Henderson, pathologist. This review included 227 cases of prostate and breast cancer biopsies from 2004-2005. The results indicated that 18 percent of the cases had incomplete results and three percent of the cases were misdiagnosed.

Breast cancer gene mutation common in Hispanic, young black women
A genetic mutation already known to be more common in Ashkenazi Jewish breast cancer patients is also prevalent in Hispanic and young African-American women with breast cancer, according to one of the largest, multiracial studies of the mutation to date.

38 Breast Cancer Patient articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
9.82